Pelvic exenterations: supralevator, infralevator, and with vulvectomy

Gynecologic Oncology
J F MagrinaA L Weaver

Abstract

The purpose of this study was to determine whether the different types (I, II, and III) of pelvic exenterations have prognostic implications in regard to operative features, postoperative complications, and survival. The records of the 133 patients who underwent pelvic exenteration at the Mayo Clinic from 1977 to 1986 were reviewed. The records were abstracted for duration of hospitalization, febrile morbidity, duration of operation, operative blood loss, number of blood transfusions, performance of a perineal phase, development of an omental carpet, vaginal reconstruction, reoperation, additional tissue resection, complications, and survival. Statistically significant differences were noted univariately between types I, II, and III in regard to the development of an omental carpet, whether or not vaginal reconstruction was done, the performance of a perineal phase, the resection of additional tissues, and the duration of hospitalization. The operative and postoperative morbidity and survival were not influenced significantly by the type of exenteration. The subclassification of the exenteration groups into type I (supralevator), type II (infralevator), and type III (with vulvectomy) is helpful to facilitate understanding of th...Continue Reading

Citations

Jan 10, 2013·The Oncologist·Joanie Mayer Hope, Bhavana Pothuri
Apr 22, 2010·Journal of Minimal Access Surgery·H PatelK Kothari
Feb 15, 2016·Journal de gynécologie, obstétrique et biologie de la reproduction·H SardainJ Levêque
Jan 3, 2016·Journal of Minimally Invasive Gynecology·Shailesh PuntambekarShivam Vatsal
Jul 24, 2012·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·G BaiocchiA Lopes
Jan 17, 2012·Surgical Oncology·M PeirettiA Maggioni
May 5, 2009·Gynecologic Oncology·Angelo MaggioniC Paul Morrow
Sep 9, 2008·Gynecologic Oncology·Laszlo UngarZoltan Novak
Jul 22, 2008·Gynecologic Oncology·Luis M ChivaNatalia Carballo
Oct 3, 2006·The Lancet Oncology·Michael Höckel, Nadja Dornhöfer
Dec 1, 2006·Gynécologie, obstétrique & fertilité·G FerronM Soulié
Apr 20, 2010·Journal of Surgical Oncology·Christina FotopoulouJalid Sehouli
Aug 8, 2006·Gynecologic Oncology·Simone MarnitzAchim Schneider
Oct 27, 2005·Gynecologic Oncology·Gwénaël FerronMichel Soulié
Aug 30, 2005·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·D Q A NguyenM G Lucas
Apr 9, 2005·Surgical Oncology Clinics of North America·Nicholas C LambrouHervy E Averette
Jul 15, 2015·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Tara L SagebielPriya R Bhosale
Jun 27, 2015·The Journal of Obstetrics and Gynaecology Research·Yin WangYan-Fang Li
Apr 30, 2015·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·H SardainJ Levêque
Jul 15, 2009·Gynecologic Oncology·Jeffrey M Fowler
Jun 9, 2016·Expert Review of Anticancer Therapy·Valentina ZanfagninAndrea Mariani
Mar 16, 2006·Annals of Surgical Oncology·Timothy M PawlikMiguel A Rodriguez-Bigas
Apr 24, 2018·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Giorgio BoganiFrancesco Raspagliesi
Jan 21, 2014·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Vito ChianteraGiuseppe Filiberto Vercellino
Apr 2, 2014·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Vito ChianteraGiuseppe Filiberto Vercellino
Sep 26, 2014·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Hugo SardainJean Levêque
Jan 26, 2016·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Margherita DessoleVito Chiantera
Dec 24, 2013·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Vito ChianteraGiuseppe Filiberto Vercellino
Feb 27, 2019·La Radiologia medica·Martina SbarraRiccardo Manfredi
Jul 16, 2010·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·M Höckel
May 2, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Gwénaël FerronDenis Querleu
Jul 4, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Simone MarnitzChristhardt Köhler
Jun 22, 2010·Archives of Gynecology and Obstetrics·Gustavo Cardoso GuimarãesAdemar Lopes
Dec 6, 2012·Annals of Surgical Oncology·Glauco BaiocchiAdemar Lopes
Sep 13, 2013·Archives of Gynecology and Obstetrics·P PathirajaS Kehoe
Jan 1, 2010·Oncology Letters·Angiolo GadducciLuca Cionini
Oct 3, 1999·Seminars in Surgical Oncology·P J CroweA S Ketcham
Nov 30, 2019·Journal of Surgical Oncology·Gustavo A LaporteWilliam A Casteleins
Jun 27, 2018·Chinese Medical Journal·Lei LiMing Wu
Mar 5, 2008·Arquivos De Gastroenterologia·Sergio Renato Pais CostaRenato Arioni Lupinacci
Jun 24, 2019·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·F CarboniM Valle
Oct 18, 2020·Archives of Gynecology and Obstetrics·Ignacio ZapardielUNKNOWN VULCAN Study collaborative group
Dec 17, 2011·Bulletin du cancer·Jean-Jacques TuechFrancis Michot

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.